Arabic Arabic English English French French German German
dark

Impact of age examined for ticagrelor monotherapy after PCI

(HealthDay)—For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor with aspirin, without increasing ischemic events, according to a study published in the July 12 issue of JACC: Cardiovascular Interventions. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tuning the immune system may enhance vaccines and ease disease

Next Post

Just 20 states reached Biden’s July 4 vaccination goal

Related Posts
Total
0
Share